Communicating a Diagnosis of Mild Cognitive Impairment or Dementia
JAMA · 16.09.2025 · 334 (11) · 1014
DOI: 10.1001/jama.2025.13006 ↗Kurz gefasst
Fachartikel in der Zeitschrift JAMA, erschienen am 16.09.2025. Verfasst von Kyra O'Brien und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurology, University of Pennsylvania Perelman School of Medicine, Philadelphia. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 9 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIA NIH HHS.
Themen: Demenz
Abstract (Originalsprache)
This JAMA Insights explores strategies for effectively communicating a diagnosis of mild cognitive impairment or dementia to patients and their care partners.
Autor:innen und Institutionen
- Department of Neurology, University of Pennsylvania Perelman School of Medicine, Philadelphia.
- Leonard Davis Institute of Health Economics, University of Pennsylvania, Philadelphia.
- Department of Medical Ethics & Health Policy, University of Pennsylvania Perelman School of Medicine, Philadelphia.
- Department of Medicine, University of Pennsylvania Perelman School of Medicine, Philadelphia.
Förderung
- NIA NIH HHS
Zitieren
APA
O'Brien, K., Largent, E. A., & Karlawish, J. (2025). Communicating a Diagnosis of Mild Cognitive Impairment or Dementia. JAMA, 334(11), 1014. https://doi.org/10.1001/jama.2025.13006
Vancouver
O'Brien K, Largent EA, Karlawish J. Communicating a Diagnosis of Mild Cognitive Impairment or Dementia. JAMA. 2025;334(11):1014. doi:10.1001/jama.2025.13006
BibTeX
@article{OBrien2025,
author = {O'Brien, Kyra and Largent, Emily A and Karlawish, Jason},
title = {Communicating a Diagnosis of Mild Cognitive Impairment or Dementia},
journal = {JAMA},
year = {2025},
volume = {334},
number = {11},
pages = {1014},
doi = {10.1001/jama.2025.13006}
}
EUVIMED